Drug Resistance Updates · 2023 · 67 citations · 32 references
MedicineOncologyPharmacologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingChemotherapy ResistanceOncogenic Signaling PathwaysReceptor Tyrosine Kinase SignalingTherapeutic ResistanceTyrosine Kinase InhibitorsEgfr InhibitionNadph Oxidase ActivityNadph Oxidase SignalingNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentResistance Mechanism ElucidationResistance To Tyrosine Kinase InhibitorsTherapeutic Tyrosine Kinase Inhibitors
32
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Tony Mok, Yi‐Long Wu, Sumitra Thongprasert et al. · New England Journal of Medicine · 2009 · 8.2K citations · Full text
Medicine, Oncology, Pharmacology +13
Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
Esra A. Akbay, Shohei Koyama, Julián Carretero et al. · Cancer Discovery · 2013 · 1.2K citations · Full text
Medicine, Immunology, Oncology +17
Narek Shaverdian, Aaron Lisberg, Krikor Bornazyan et al. · The Lancet Oncology · 2017 · 1.1K citations
Identification of Renox, an NAD(P)H oxidase in kidney
Miklós Geiszt, Jeffrey B. Kopp, Péter Várnai et al. · Proceedings of the National Academy of Sciences · 2000 · 829 citations